[Evaluation of hearing in children with solid tumors treated by chemotherapy].

Abstract	Ototoxicity of cisplatin is documented in during the last years. In material of 13 children with solid tumors (neuroblastoma, nephroblastoma, rhabdomyoscarcoma) treated with cisplatin, ototoxicity was observed in 2 cases. There were presented audiological findings. The role of otoacoustic emission measurements in monitoring of cisplatin--induced ototoxicity was underlined.
Authors	D Gryczyńska, M Rychwalska, K Pekacka, M Krawczyński, J Bodalski
Journal	Otolaryngologia polska = The Polish otolaryngology (Otolaryngol Pol) Vol. 55 Issue 2 Pg. 179-83 ( 2001) ISSN: 0030-6657 [Print] Poland
Vernacular Title	Ocena słuchu u dzieci z guzami litymi w trakcie chemioterapii.
PMID	11494735 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References	Antineoplastic Agents Cisplatin
Topics	Antineoplastic Agents (adverse effects) Audiometry, Pure-Tone Brain Neoplasms (drug therapy) Child Cisplatin (adverse effects) Hearing Loss, Sensorineural (chemically induced, diagnosis) Humans Male Neuroblastoma (drug therapy) Otoacoustic Emissions, Spontaneous (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!